Read the full article at PR Newswire: Clinical Trials & Medical Discoveries
General
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
Read the full article at PR Newswire: Clinical Trials & Medical Discoveries
